CMS Open Payments · Program Year 2024
Northern Mariana Islands
Northern Mariana Islands received $658.59 in pharmaceutical-industry payments to 4 physicians and 0 teaching hospitals across 24 transactions.
- $658.59
- Total payments
- $368.53
- To physicians
- $0.00
- To teaching hospitals
- #58
- of 59 states
In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $658.59 in payments to 4 physicians and 0 teaching hospitals in Northern Mariana Islands. That ranks Northern Mariana Islands #58 of 59 states and territories (0.0% of the US total), averaging $92.13 per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.
The verdict
Northern Mariana Islands pairs modest payment volume with a balanced mix between physicians and hospitals.
- #58
- of 59 states
- 0.0%
- of the national total
- 56.0%
- to physicians vs. hospitals
- 4
- physicians paid
What the Data Shows for Northern Mariana Islands
Northern Mariana Islands sits in the lower-volume tercile at #58 of 59 (0.0% of US dollars). The PY2024 file still records $658.59 across 24 transactions.
The distinctive cut versus volume is the hospital share: 0.0% of dollars to 0 teaching hospitals ($0.00 each). Average transaction $27.44. Leading nature of payment: "Food and Beverage" at $658.59 (100.0% of the state file; top-three natures 100.0%).
Northern Mariana Islands sits in the 3rd percentile (lower-volume tier). Just above: American Samoa ($731.62). Just below: Armed Forces Americas ($164.64). For context: top-ranked California ($342.4M) is 519879.5× larger than Northern Mariana Islands. CMS Sunshine Act framework and methodology.
Physician vs Hospital Payments
How pharmaceutical payments in Northern Mariana Islands are distributed between physicians and teaching hospitals.
Physician Payments
$368.53
56.0% of total · 4 recipients · $92.13 avg
Teaching Hospital Payments
$0.00
0.0% of total · 0 hospitals · $0.00 avg
Payment Breakdown by Type
Northern Mariana Islands has 1 types of pharmaceutical payments. "Food and Beverage" accounts for 100.0%.
Payment categories in Northern Mariana Islands
Top categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of State |
|---|---|---|---|
| Food and Beverage | $658.59 | 24 | 100.0% |
Read with this Northern Mariana Islands Open Payments read
Volume neighbors, physician-share peers, and the national nature catalog, not the same three guides on every state page.
- Next higher total: American Samoa ($731.62)
- Next lower total: Armed Forces Americas ($164.64)
- Nearest physician-share mix: Michigan (59.1% to physicians)
- Nearest physician-share mix: Washington (65.8% to physicians)
- Nearest physician-share mix: Alaska (67.9% to physicians)
- National catalog for leading nature here: Food and Beverage (100.0% of Northern Mariana Islands)
- State payment rankings (includes Northern Mariana Islands at #58)
- How Open Payments natures are defined
Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.
Read our methodology - how this data is sourced, computed, and verified.
Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024
What Northern Mariana Islands totals can and cannot tell you
The aggregate payment figure for Northern Mariana Islands measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.
Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.